Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DR26F17ZR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,394
Award facts
- Contract value 100% obligated
- $23,393.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,393.68 to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials, a biosimilar medication. This firm fixed-price delivery order, issued on November 13, 2025, with an ultimate completion date of November 14, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical distribution infrastructure and federal procurement capabilities.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supports global pharmaceutical supply for military healthcare systems. AmerisourceBergen's role as a critical pharmaceutical distributor enables it to fulfill diverse federal medical procurement requirements across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's selection reflects its demonstrated capability to compete and perform under DLA's comprehensive medical supply chain framework.
Quick answers
Who was awarded contract SPE2DR26F17ZR?
SPE2DR26F17ZR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F17ZR worth?
The government has obligated $23,394 on SPE2DR26F17ZR.
Is contract SPE2DR26F17ZR an order under another contract?
Yes. SPE2DR26F17ZR is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F17ZR competed?
The extent of competition for SPE2DR26F17ZR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award